Drug Topics

NOVEMBER 5, 2024

Companies like ShiftRx are using technology to help solve the staffing shortage crisis in health care.

227

227

Pharmacy Times

NOVEMBER 5, 2024

Using in vitro models, study investigators predict the risk of bone metastasis in breast cancer based on correlations with their in vivo behaviors and potential.

153

153

Drug Topics

NOVEMBER 5, 2024

A collection of independent pharmacies was the next in line to file suits against major pharmacy benefit managers for alleged drug price fixing.

Independent Pharmacies 220

Independent Pharmacies 220

Pharmacy Times

NOVEMBER 5, 2024

The approval comes after the phase 3 clinical trials MVOR-1 (NCT05296629) and MVOR-2 (NCT05343455).

FDA 143

FDA 143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

NOVEMBER 5, 2024

Erin Rexroth, director of marketing at NCPA, discusses how smaller pharmacies can compete with large chains when it comes to digital marketing.

187

187

Pharmacy Times

NOVEMBER 5, 2024

About 41% and 30% of patients with chronic spontaneous urticaria (CSU), respectively, achieved well-controlled disease status and complete response when treated with dupilumab.

138

138

Pharmacy Times

NOVEMBER 5, 2024

Kristi Veis discusses the importance of flu vaccinations and the role of pharmacists in administering them.

Vaccines 132

Vaccines 132

Fierce Pharma

NOVEMBER 5, 2024

Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial. | Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial.

126

126

Pharmacy Times

NOVEMBER 5, 2024

Less than 16% of high-risk lung cancer individuals have heard or discussed lung cancer screenings with a health care provider.

Communication 132

Communication 132

PharmaVoice

NOVEMBER 5, 2024

Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.

124

124

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

NOVEMBER 5, 2024

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a local report fueled fears of a potentially escalating insurance fraud investigation in China. | AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially escalating insurance fraud investigation in China.

Insurance 124

Insurance 124

Pharmacy Times

NOVEMBER 5, 2024

The results found that women, non-binary, and sexual minority students are at the highest risk.

122

122

STAT

NOVEMBER 5, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Election Day is finally here. What to say? If you’re feeling at all grateful for STAT’s journalism today, consider supporting our newsroom. We’re currently offering 40% off our annual subscription.

122

122

Fierce Pharma

NOVEMBER 5, 2024

Despite witnessing modest growth in demand over the past three months, Apellis Pharmaceuticals’ complement inhibitor for geographic atrophy (GA), Syfovre, may have hit a performance “nadir” in 2024 | Over the latest earnings stretch, Apellis' Syfovre saw sales down about 2% from the previous quarter despite an overall demand increase of about 7%.

116

116

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

NOVEMBER 5, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning. Hope everyone takes it easy in what will be a long day today. Now let’s get into the biotech news.

116

116

pharmaphorum

NOVEMBER 5, 2024

Beam shines a light on phase 1/2 data with its base editing candidate for sickle cell disease ahead of a full presentation at ASH next month

115

115

Fierce Healthcare

NOVEMBER 5, 2024

Yet another major insurer is taking the federal government to court over all-important star ratings results. | Elevance Health is hitting back at CMS star ratings over statistical variation and inability of replication in the latest lawsuit to face the feds.

Insurance 114

Insurance 114

Drug Topics

NOVEMBER 5, 2024

The drug is also approved to treat schizophrenia and bipolar depression.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

NOVEMBER 5, 2024

Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.Shares in the company gained almost 24% after it announced that the end of phase 2 meeting with the US regulator had firmed up plans for a phase 3 trial of bitopertin in EPP, as well as the potential for accelerated approval.

110

110

Drug Topics

NOVEMBER 5, 2024

“Emrosi has potential to become the best-in-class oral medication to treat the condition,” said the CEO of Journey Medical.

FDA 112

FDA 112

pharmaphorum

NOVEMBER 5, 2024

Cancer Research UK awards £5.

110

110

Pharmacy Times

NOVEMBER 5, 2024

The novel therapy demonstrated safety and efficacy in a clinical trial.

FDA 107

FDA 107

pharmaphorum

NOVEMBER 5, 2024

Learn the importance of having a standardised data model as your single source of truth in this insightful video interview. Gain valuable insights on data management and standardisation processes.

105

105

PioneerRx

NOVEMBER 5, 2024

Well, here we are: November, only two months until we welcome in the new year. As this year draws to a close, the last two months offer a powerful opportunity to.

104

104

Drug Topics

NOVEMBER 5, 2024

A conversation with Lauren Angelo, PharmD, MBA, associate dean of academic affairs and an associate professor of pharmacy practice at Rosalind Franklin University of Medicine and Science College of Pharmacy.

Vaccines 98

Vaccines 98

pharmaphorum

NOVEMBER 5, 2024

Learn about four key strategies for optimising your scientific medical congress strategy to maximise impact and engagement.

97

97

Pharmaceutical Technology

NOVEMBER 5, 2024

Ascendis Pharma will license its TransCon technology to Novo to develop therapies for metabolic and cardiovascular diseases.

97

97

STAT

NOVEMBER 5, 2024

Tuesday’s oral arguments before the Supreme Court in a case involving billions in Medicare payments to hospitals revealed a split among the justices willing to show their cards.  The case, Advocate Christ Medical Center v. Becerra, concerns Medicare payments to safety net hospitals, known as disproportionate share hospital, or DSH, payments, which are designed to compensate them for treating low-income patients.

Hospitals 96

Hospitals 96

Pharmacy Times

NOVEMBER 5, 2024

Pegfilgrastim (Neulasta; Amgen) treats neutropenia that is caused by cancer medications and helps the bone marrow to create new white blood cells.

94

94

STAT

NOVEMBER 5, 2024

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and crisp autumn breezes are wafting by. Moreover, this is an exciting day on this side of the pond, where millions of voters are casting their ballots in hopes of changing their world.

Chemotherapy 96

Chemotherapy 96

The Guardian - Pharmaceutical Industry

NOVEMBER 5, 2024

Pharmaceutical’s weight loss pill described as ‘underwhelming’, also piling pressure on share price AstraZeneca shares tumbled on Tuesday wiping £14bn off the value of Britain’s biggest drug maker, after a report that dozens of senior executives at its China unit could be implicated in an insurance fraud case in the country’s pharmaceutical sector. Also putting pressure on the share price, early data on AstraZeneca’s experimental weight loss pill published on Monday was described as “somewhat un

Insurance 107

Insurance 107

Fierce Healthcare

NOVEMBER 5, 2024

Introducing new technology in the healthcare sector can be a challenge, especially when t | This week on "Podnosis," we explore how startups can better align with providers to create impactful tools that integrate seamlessly into healthcare workflows.

84

84

Outsourcing Pharma

NOVEMBER 5, 2024

Innovative radiotherapy offers a precision treatment alternative.

84

84